Medical News / Directly from ASH Meeting 2020, Study Reports on Thrombotic Rates Among COVID-19 Patients

Findings from a retrospective analysis reported a 7.5% prevalence of thrombotic events among coronavirus disease 2019 (COVID-19) patients. The study was conducted at 3 university health systems in the Chicago Metropolitan Area. The investigators also evaluated and identified risk factors for thrombosis. The study, presented at the American Society of Hematology (ASH) 2020 Conference, was led by Stephanie Berg, DO, Division of Hematology and Oncology, Loyola University Medical Center, and was conducted between March 2020 – May 2020. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

The modes of multiple myeloma assessment and screening has progressed over decades in near-alignment with the ... read more
A new study presented at the American Society of Hematology (ASH) 2020 Annual Meeting this weekend ... read more
A mobile health (mHealth) app may help children manage pain and symptoms related to sickle cell ... read more
Cognitive and emotional functions in pediatric patients should not be overlooked when assessing potential for sickle ... read more